| Primary |
| Product Used For Unknown Indication |
32.5% |
| Drug Use For Unknown Indication |
24.6% |
| Epilepsy |
15.1% |
| Convulsion |
4.4% |
| Drug Exposure During Pregnancy |
4.1% |
| Bipolar Disorder |
3.3% |
| Schizophrenia |
3.3% |
| Bipolar I Disorder |
1.7% |
| Depression |
1.6% |
| Maternal Exposure Timing Unspecified |
1.3% |
| Grand Mal Convulsion |
1.2% |
| Status Epilepticus |
1.2% |
| Psychotic Disorder |
1.0% |
| Partial Seizures |
0.9% |
| Convulsion Prophylaxis |
0.8% |
| Mania |
0.7% |
| Myoclonic Epilepsy |
0.7% |
| Affective Disorder |
0.7% |
| Schizoaffective Disorder |
0.5% |
| Agitation |
0.5% |
|
| Toxicity To Various Agents |
25.6% |
| Convulsion |
6.1% |
| Abortion Spontaneous |
5.4% |
| Drug Interaction |
5.0% |
| Overdose |
4.8% |
| Weight Increased |
4.8% |
| Tremor |
4.7% |
| Drug Level Decreased |
4.3% |
| Sudden Unexplained Death In Epilepsy |
4.3% |
| Status Epilepticus |
4.2% |
| Thrombocytopenia |
3.8% |
| Foetal Anticonvulsant Syndrome |
3.7% |
| Somnolence |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Alopecia |
3.2% |
| Foetal Exposure During Pregnancy |
3.2% |
| Vomiting |
2.9% |
| Drug Exposure During Pregnancy |
2.5% |
| Hyperammonaemia |
2.3% |
| Neutropenia |
2.3% |
|
| Secondary |
| Epilepsy |
21.8% |
| Product Used For Unknown Indication |
19.5% |
| Drug Use For Unknown Indication |
18.2% |
| Convulsion |
6.3% |
| Bipolar Disorder |
5.1% |
| Schizophrenia |
4.0% |
| Depression |
3.9% |
| Agitation |
2.5% |
| Bipolar I Disorder |
2.3% |
| Grand Mal Convulsion |
2.1% |
| Psychotic Disorder |
1.9% |
| Myoclonic Epilepsy |
1.7% |
| Status Epilepticus |
1.6% |
| Schizoaffective Disorder |
1.4% |
| Partial Seizures |
1.4% |
| Affect Lability |
1.3% |
| Mania |
1.3% |
| Hallucination, Auditory |
1.2% |
| Affective Disorder |
1.2% |
| Ill-defined Disorder |
1.2% |
|
| Convulsion |
8.3% |
| Vomiting |
7.3% |
| Thrombocytopenia |
7.2% |
| Weight Increased |
7.0% |
| Drug Interaction |
6.9% |
| White Blood Cell Count Decreased |
6.5% |
| Grand Mal Convulsion |
5.8% |
| Suicide Attempt |
5.5% |
| Somnolence |
5.1% |
| Status Epilepticus |
4.7% |
| Tremor |
4.2% |
| Neutropenia |
4.0% |
| Pyrexia |
3.9% |
| Encephalopathy |
3.7% |
| Overdose |
3.6% |
| Pancytopenia |
3.6% |
| Drug Ineffective |
3.3% |
| Drug Level Decreased |
3.3% |
| Loss Of Consciousness |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
|
| Concomitant |
| Epilepsy |
16.5% |
| Schizophrenia |
16.4% |
| Product Used For Unknown Indication |
14.0% |
| Drug Use For Unknown Indication |
11.2% |
| Convulsion |
4.6% |
| Bipolar Disorder |
4.5% |
| Depression |
4.5% |
| Schizoaffective Disorder |
3.3% |
| Hiv Infection |
3.3% |
| Hypertension |
2.6% |
| Affective Disorder |
2.6% |
| Psychotic Disorder |
2.4% |
| Prophylaxis |
2.3% |
| Infection Prophylaxis |
2.1% |
| Schizophrenia, Paranoid Type |
2.1% |
| Stem Cell Transplant |
1.8% |
| Constipation |
1.6% |
| Insomnia |
1.6% |
| Bipolar I Disorder |
1.4% |
| Rheumatoid Arthritis |
1.2% |
|
| Vomiting |
10.1% |
| Granulocytopenia |
9.8% |
| Epilepsy |
8.0% |
| White Blood Cell Count Decreased |
7.6% |
| Weight Increased |
6.8% |
| White Blood Cell Count Increased |
5.8% |
| Convulsion |
5.7% |
| Somnolence |
5.2% |
| Tremor |
4.2% |
| Drug Ineffective |
4.0% |
| Pneumonia |
3.9% |
| Stomatitis |
3.5% |
| Pyrexia |
3.5% |
| Death |
3.3% |
| Thrombocytopenia |
3.2% |
| Tachycardia |
3.1% |
| Hospitalisation |
3.1% |
| Status Epilepticus |
3.1% |
| Weight Decreased |
3.0% |
| Neutropenia |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
20.7% |
| Epilepsy |
11.6% |
| Lennox-gastaut Syndrome |
11.4% |
| Mental Disorder |
10.9% |
| Drug Use For Unknown Indication |
8.9% |
| Bipolar I Disorder |
6.6% |
| Psychotic Disorder |
5.2% |
| Convulsion |
4.1% |
| Depression |
3.2% |
| Mania |
2.7% |
| Bipolar Disorder |
2.0% |
| Schizophrenia |
2.0% |
| Myoclonic Epilepsy |
1.8% |
| Myoclonus |
1.8% |
| Agitation |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Migraine Prophylaxis |
1.4% |
| Complex Partial Seizures |
1.1% |
| Infection |
0.9% |
| Pneumonia |
0.9% |
|
| Drug Interaction |
27.2% |
| Dyskinesia |
9.6% |
| Status Epilepticus |
8.0% |
| Hyperammonaemic Encephalopathy |
5.6% |
| Convulsion |
4.8% |
| Homicide |
4.8% |
| Somnolence |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Anticonvulsant Drug Level Decreased |
4.0% |
| Gait Disturbance |
4.0% |
| Lung Disorder |
4.0% |
| Epilepsy |
2.4% |
| Overdose |
2.4% |
| Psychotic Disorder |
2.4% |
| Thought Blocking |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Coma |
1.6% |
| Encephalopathy |
1.6% |
| Grand Mal Convulsion |
1.6% |
| Hepatic Enzyme Increased |
1.6% |
|
